Finar

Ahmedabad, India Founded: 1998 • Age: 28 yrs Acquired By Aceto
Manufacturer of excipients, solvents, lab chemicals, food additives, and other fine chemicals

About Finar

Finar is a Healthcare company based in Ahmedabad (India) founded in 1998, and was acquired by Aceto in May 2021. Manufacturer of excipients, solvents, lab chemicals, food additives, and other fine chemicals. The company has 238 employees. Its Indian entity Finar Limited reported revenue of β‚Ή331 Cr. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Excipient Production. Its competitors include Scope Ingredients, Crest Cellulose and Vikram Thermo.

Company details

Finar is engaged in the manufacturing of lab chemicals, excipients, solvents, food additives, and others and also offers related services which include CoA and MSDS reports. Their products find applications in industries such as pharma, foods, refinery, chemicals, automobiles, and electronics. Their FDA approved facility has capabilities for the manufacturing of USPBPJP and IP grade products and they specialize in manufacturing high-end pharmaceutical excipients. They have filed DMFs for select products with the US FDA. Their excipients can be used for formulating solid, semi-solid and injectable dosage forms and also for transdermal patches.

  • Headquarters Ahmedabad, India
  • Employees 238
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website finarchemicals.com
  • Social LinkedIn Facebook
  • Acquired by Aceto (May 2021)
  • Legal Name Finar Limited
  • Date of Incorporation 02 Sep, 1998
  • Jurisdiction Ahmedabad, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹331 Cr

    FY 2023 · +16% YoY

  • Net Profit
    ₹62.80 Cr

    FY 2023 · 19% margin

  • EBITDA
    ₹91.28 Cr

    FY 2023 · 28% margin

  • Investors
  • Employee Count
    238
  • Acquired by
    Aceto

    (May 2021)

Investors in Finar

Finar has secured backing from 1 investor. Prominent investors backing the company include Aceto.

All
InvestorDescriptionFounded YearDomainLocation
APIs, intermediates, formulations, and chemicals are manufactured and distributed.
1947aceto.comNew York, United States
Premium access

Investor details for Finar

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Finar Limited (Finar)

Finar Limited is the primary company behind Finar. The board of Finar Limited currently have 4 directors; the longest-serving is Arpit Chandrakant Butala, appointed in 2019. 14 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Arpit Chandrakant Butala
DIN 10348219
CFO17 Jun 20197 yrs 5 moFinar Limited
James Douglas Steele
DIN 09155919
Director13 May 20215 yrs 6 moFinar Limited
Varun Vijay Rao
DIN 02509615
Director13 May 20215 yrs 6 moFinar Limited
Sunil Punjabi
DIN 03349868
Managing Director07 Jan 20233 yrs 10 moFinar Limited

People of Finar

18 people are tracked at Finar (9 in leadership, 9 in team); the tracked headcount is 238.

NameRoleGroup
Chief Financial OfficerLeadership
Prantik Mukhopadhyay
Business DirectorLeadership
Mahesh Tendulkar
General Manager - Sales ( West )Leadership
President - Asia PacificLeadership
Bishwajeet Roy
Director & Chief Operating OfficerLeadership
Mayank Shah
Director WorksLeadership
Yeshwant Samant
Technical DirectorLeadership
Ranjan De Mazumdar
General Manager - Sales (south & East)Leadership
Ravinder Tanwar
General Manager - Business DevelopmentLeadership
Vineet Gupta
Area Business ManagerTeam
Darshan Sampat
Accounts ExecutiveTeam
Rakesh Bagade
MarketingTeam
Prasenjit Bhattacharya
Manager ‐ Government Business & TendersTeam
Velma. Sanjay Salvi.
Manager-order Management And Customer Service-indiaTeam
Vishal Vyas
Senior Manager Finance AccountTeam
Harendra Kumar
Sr.marketing ExecutiveTeam
Rohit Patil
Sr Sales And Marketing Pharma Excipients And BiopharmaTeam
Gaurang Kanzariya
Senior ChemistTeam
Premium access

Complete people profiles for Finar

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Finar

Figures of Finar Limited, the primary company behind Finar, for FY 2023. Revenue was ₹331 Cr (+16% year on year). Net profit was ₹62.80 Cr (19% margin). EBITDA was ₹91.28 Cr (28% margin). Revenue has grown at a compounded annual rate of +23% over three years and +20% over five years.

  • ₹331 CrRevenue · FY 2023 · +16% YoY
  • ₹62.80 CrNet profit · 19% margin
  • ₹91.28 CrEBITDA · 28% margin
  • ₹9.75 CrPaid-up capital
  • 238Employees (provident fund records)
  • +23%Revenue CAGR, 3 years
  • +20%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Finar Limited are on its company page.

Premium access

Detailed financial statements for Finar

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Finar

2 dated milestones of Finar across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded Finar is founded.
  2. Exit Acquired by Aceto.

Competitors of Finar

Finar has 3 listed competitors in our database. They include Scope Ingredients, Crest Cellulose and Vikram Thermo.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
scope-india.com1959Chennai, India89
Formulations, warehousing, and logistics services for pharmaceuticals are provided.
crestcellulose.com2011Hyderabad, India77
Pharmaceutical excipients and food ingredients are developed and manufactured.
vikramthermo.com1984Ahmedabad, India107
Manufacturer of excipients for small molecules
Premium access

Detailed competitors of Finar

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Finar

Websites that share an audience with Finar (finarchemicals.com).

Similar websites

Websites whose visitors overlap most with Finar. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
english.poch.com.pl
english.poch.com.pl
100%
–
biospectra.us
99%
680.7K#3,432,985View details
ptf.content-manager.pl
ptf.content-manager.pl
69%
–

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Finar (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Finar

Premium access

Complete news archive for Finar

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Finar

Finar was founded in 1998.

Finar is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Finar has 238 employees.

The primary company behind Finar, Finar Limited, reported revenue of β‚Ή331 Cr for FY 2023, up 16% year on year.

Finar is engaged in the manufacturing of lab chemicals, excipients, solvents, food additives, and others and also offers related services which include CoA and MSDS reports. Their products find applications in industries such as pharma, foods, refinery, chemicals, automobiles, and electronics. Their FDA approved facility has capabilities for the manufacturing of USPBPJP and IP grade products and they specialize in manufacturing high-end pharmaceutical excipients. They have filed DMFs for select products with the US FDA. Their excipients can be used for formulating solid, semi-solid and injectable dosage forms and also for transdermal patches.

Finar's top competitors include Crest Cellulose, Scope Ingredients and Vikram Thermo.

Finar has 1 investor. Key investors include Aceto.

Finar operates through Finar Limited.

Yes. Finar was acquired by Aceto in May 2021.

The legal entities of Finar currently have 5 directors, including James Douglas Steele, Arpit Chandrakant Butala, Varun Vijay Rao and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available